Bartlett & Co’s BioNTech BNTX Stock Holding History

Bartlett & Co’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-650	Closed	-$81K	–	1124
2023 Q1	$81K	Hold	650	–	–	﹤0.01%	495
2022 Q4	$98K	Hold	650	–	–	﹤0.01%	473
2022 Q3	$88K	Buy	+650	New	+$99.4K	﹤0.01%	473

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bartlett & Co's BNTX Position: Q2 2023 in Review

Bartlett & Co sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 650 shares — an estimated $81K sold.

Bartlett & Co first reported a position in BNTX in Q3 2022 and held it in 3 quarters. The position peaked at $98K in Q4 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

Bartlett & Co reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
Bartlett & Co sold 650 BioNTech shares in Q2 2023, an estimated $81K.
Bartlett & Co first reported a position in BioNTech in Q3 2022 and held it in 3 quarters.
Bartlett & Co's BioNTech position peaked at $98K in Q4 2022.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Bartlett & Co's 13F filing for Q2 2023, filed 14 Jul 2023.